TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
LLY

Eli Lilly and Company

Healthcare · Drug Manufacturers - General

1,181.90$ +2.7% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

Eli Lilly and Company (LLY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 10,690 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow LLY
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
1,662 2,117 340 1,651 1,881 1,744 437 1,518 2,122 1,449 311 1,052 1,510 1,964 382 2,495 1,807 1,815 1,697 1,776 1,631 2,157 2,523 1,183 2,217 1,580 1,731 632 2,190 -312 1,166 1,466 3,712 2,474 1,666 3,087 8,836 3,225 5,333 10,690 28,084
393 345 387 396 373 412 423 425 416 346 357 247 288 341 274 324 358 368 350 369 382 446 436 349 363 375 362 366 411 388 401 414 467 485 463 479 470 586 509 534 2,099
62 67 69 70 70 72 68 70 69 73 76 80 76 82 72 77 72 88 86 92 90 75 101 92 85 93 131 162 216 120 159 211 133 142 154 185 151 136 161 201 649
304 269 1,059 371 357 -739 66 2,014 263 719 -3,573 279 216 3,731 60 -168 -9.6 -154 95 -205 805 459 206 -409 -569 103 -141 -657 1,043 – – – – – – – – – – – –
186 732 -995 -124 593 3,730 -1,270 -662 294 -741 -714 -802 -247 77 -1,408 927 249 -515 -103 221 -667 -475 -34 -70 928 -836 164 -840 793 -3,172 -1,751 -1,399 -9.8 -2,225 -3,364 -2,263 1,208 -3,674 -1,664 -670 -4,800
228 465 169 222 448 494 237 1,858 300 624 401 285 341 327 258 523 415 820 492 531 456 394 881 814 652 556 904 836 4,001 1,651 986 1,403 4,171 1,747 3,267 1,804 224 2,547 2,326 2,933 8,030
-795 -1,178 -1,430 -2,249 -1,758 1,653 -170 3,133 -398 -659 -7,679 61 -424 -41 -1,061 -210 -314 -674 -1,284 -483 -617 -379 -1,038 -827 -955 -861 -689 -459 -3,081 -2,924 -1,178 -2,199 -4,005 -1,921 -3,352 -1,835 -2,983 -2,802 -3,916 -15,396 -25,097
538 541 547 549 548 548 587 579 573 573 637 598 587 587 671 674 672 670 775 768 770 773 886 884 882 884 1,017 1,018 1,016 1,018 1,169 1,172 1,171 1,168 1,346 1,347 1,345 1,346 1,548 1,546 5,785
0.0 -300 0.0 -200 0.0 -100 -1,100 -951 -1,000 -1,100 -3,500 -3,500 -600 -300 -500 -500 -500 500 0.0 -500 -500 -750 -1,500 -1,500 -1,500 1,500 -750 -750 -750 750 0.0 0.0 -446 -2,054 -1,200 -692 -708 -1,508 -2,356 -1,601 -6,173
-0.4 1,295 -133 1,860 1,101 171 -2,003 753 429 92 5,699 -286 -506 -222 1,472 -996 395 -580 -3.7 200 308 -2.6 -210 768 -376 -243 2,461 1,595 1,595 – – – 1,875 3,042 4,612 825 2,615 -0.5 1,025 11,577 15,216
-600 275 -876 1,060 501 -542 -3,867 -831 433 -1,640 1,368 -886 -1,693 -1,114 107 -1,673 -279 -1,292 -1,058 -1,083 -463 -1,527 -2,878 -124 -1,263 -1,141 412 -1,033 572 3,545 -311 1,556 211 -225 1,380 -1,245 531 -2,879 -3,470 8,426 2,608
251 1,093 -1,965 453 654 2,812 -3,452 3,733 2,143 -962 -5,962 254 -726 774 -639 666 1,230 62 -655 218 568 30 -1,359 164 -5.5 -550 1,479 -851 -314 438 -358 763 145 -101 -175 283 6,416 -2,524 -1,986 3,668 5,574
1,432 1,652 171 1,430 1,433 1,250 200 -341 1,822 825 -89 766 1,169 1,637 124 1,972 1,392 996 1,205 1,244 1,176 1,762 1,642 370 1,565 1,024 827 -204 -1,812 -1,963 180 63 -459 727 -1,601 1,283 8,612 678 3,007 7,757 20,054

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?